Cannabis Report
Home > Boards > US OTC > Cannabis >

United Cannabis Corp. (CNAB)

Add CNAB Price Alert      Hide Sticky   Hide Intro
Moderator: captainscotty, Panzer
Search This Board: 
Last Post: 7/16/2018 7:35:45 AM - Followers: 181 - Board type: Free - Posts Today: 0

 Prana Bio Nutrient Medicinals

The Company’s Chief Executive and Chief Technical Officers have been involved with medical cannabis since it was permissible in California in 1999, turning their focus to Colorado during the infancy stage of legalizing medical cannabis in 2009. With the benefit of more than 30 years’ combined experience, United Cannabis has accumulated an extensive knowledgebase across the spectrum of the cannabis industry, including engineered facilities, security, regulatory compliance, genetics, cultivation, good manufacturing practices (GMP), proprietary extraction methods, branding, retail operations (SOP), marketing and wholesale distribution.


UCANN History 

The Company’s Chief Executive and Chief Technical Officers have been involved with medical cannabis since it was permissible in California in 1999, turning their focus to Colorado during the infancy stage of legalizing medical cannabis in 2009. With the benefit of more than 30 years’ combined experience, United Cannabis has accumulated an extensive knowledgebase across the spectrum of the cannabis industry, including engineered facilities, security, regulatory compliance, genetics, cultivation, good manufacturing practices (GMP), proprietary extraction methods, branding, retail operations (SOP), marketing and wholesale distribution.

Once cannabis was approved for medical use in Colorado, the team began working closely with patients who were finding relief from a variety of chronic conditions and disease, in order to optimize their results. The results were extremely encouraging, as indicated by patient testimonials. With success, the patient base grew, providing more data, and in turn, evidence for the effectiveness of particular therapies. These cannabinoid sequencing protocols serve as the basis for United Cannabis’ Prana Bio Nutrient Medicinals and A.C.T. Now Programs.

Accredited with observational data from more than 15,000 patients to date, the Company’s success with Prana Bio Nutrients and A.C.T. Now Program garnered significant attention within the medical community, including Brent Reynolds Ph.D, William Yarosh Ph.D, and Dr. Barry Bialek  (listed below) who went on to join the United Cannabis Medical Advisory Board

United Cannabis remains dedicated to advancing the use of cannabinoids in medicine with a focus on the refinement of genetics for medical grade strains of CBD-rich cannabis plants. The Company is also steadfast in its mission to bring best practices to the industry across all aspects of operation, planning, products, governance and patient care.



Earnest Blackmon (Board Chairman and Chief Executive Officer)

Earnest Blackmon is a horticulturalist and entrepreneur with over 20 years experience, including 5 years in the Commercial Cannabis Industry. Mr. Blackmon is currently an owner and the master grower at RiverRock Colorado and is responsible for the production, processing, workflow management, JIT inventory control, security, staffing, training and recruiting. Mr. Blackmon has developed a proprietary grow method based on an organic standard to aid in stable chemical synthesis to limit side reactions that diminish yield. Mr. Blackmon’s skill with operations, project management, quality control and cultivation insure that every United Cannabis production facility produces consistent high grade organic cannabis to meet the demands of our patients.

Tony Verzura (Chief Technical Officer & Board Member)

Tony Verzura oversees the A.C.T. Now Program, product manufacturing, quality assurance, product development, product training, staffing, and brand awareness. Mr. Verzura works hand in hand with the affiliated partners to help coordinate on boarding patient programs, standard operating procedures, and ensures company goals are being met worldwide. Mr. Verzura has been apart of over 30 Awards worldwide, including 5x 1st Place CBD Concentrate Awards, and has been featured on CNBC Money Talk as an honorary guest speaker. He has attended countless cannabis business conferences and events throughout the United States, Jamaica, Canada, Amsterdam, and Spain. He is a weekly panelist on the highly publicized educational YouTube show called Hash Church hosted by Bubbleman’s World.  His publications include The Washington Post, High Times, Culture Magazine, DOPE Magazine, Skunk Magazine, Sensi Seeds, and Frank 151.

Jon Sawyer (Securities Counsel)

Jon Sawyer’s practice emphasizes Securities and Corporate Law. Sawyer served three years with the Securities and Exchange Commission’s regional office in Denver where he represented the Commission in civil and administrative enforcement actions. He participated as co-counsel with Assistant United States Attorneys in the prosecution of a criminal enforcement matter and he reviewed filings for Public Securities Offerings. Has over 22 years experience in advising publicly-held companies in connection with public and private offerings, SEC reporting, NASDAQ and exchange listings; and other Securities Law matters. John Sawyer advises the company with SEC reporting, employee stock incentive plans, employment agreements, miscellaneous contracts and corporate governance issues. Jon graduated from the University of Wyoming (BS, Statistics, 1968) ; (J.D. 1974) ; Bar Admissions: Wyoming, 1974, Colorado, 1977.

Brent A. Reynolds, Ph.D. (Chief Medical Advisor)

Brent A. Reynolds, Ph.D., attended the University of Calgary, where he received his M.Sc. and Ph.D. in 1989 and 1994, respectively. While working on his Ph.D. thesis Reynolds co-discovered the existence of stem cells in the adult mammalian brain, a finding that overcame a century old dogma that the mature brain did not have the capacity to repair itself. After graduating, Reynolds co-founded the first neural stem cell company, NeuroSpheres, Ltd., where he was a director and vice president of research. Here he developed a strong patent portfolio in the neural stem cell field, developing and protecting protocols related to the application of stem cell technology in brain repair. Today, these patents and technology have been licensed to numerous biotechnology companies that are testing the efficacy in over half a dozen clinical trials for diseases such as spinal cord injury, stroke, ALS and pediatric disorders.  After a brief hiatus, where Reynolds studied and practiced Traditional Chinese Medicine, he returned to industry working with StemCell Technologies in Vancouver, Canada. In 2004, Reynolds returned to academic science as a professor at the Queensland Brain Institute at the University of Queensland in Australia where he continued refining the application of neural stem cells for repairing the damaged brain.  In 2008, Reynolds was recruited to the department of Neurosurgery at the University of Florida and has focused his efforts on studying aggressive pediatric and adult brain cancer and developing novel translational approaches to combat this lethal disease. Working with a multidisciplinary group of scientists, the team is taking the unique approach that cancer can be managed as a chronic disease by applying the principles that have been used in ecology to manage wildlife and pest populations. Based on the lessons learned over the past 80 years by ecologists, the team is focused on using multimodal low toxicity therapeutics to enforce a stable tumor population that exists below a threshold that has any harmful effects.  Dr. Reynolds has more than 60 publications, including papers in Science, Cell and Nature, with several manuscripts receiving over 1,000 citations. In addition, he is an inventor on 18 granted US patents.  Dr. Reynolds is currently a professor in the department of neurosurgery at UF; adjunct professor at the University of New South Wales, Sydney, Australia; an honorary professor at the Queensland Brain Institute, Australia; and program director for StepAhead, Australia. NIH, NHMRC and numerous foundations have funded his lab.

Barry Bialek MD. (Medical Advisor)

Dr. Barry Bialek is a dual citizen of the USA and Canada. He received his BA Math & General Science, and his teaching certification for Secondary Education in 1974. He received his MD, Doctor of Medicine from George Washington University in 1985, and did his residency in family and community medicine at Wellesley Hospital, University of Toronto. Dr. Bialek did his fellowship in Obstetrics Mt. Sinai Hospital, University of Toronto. He was a lecturer from 93’ – 96’, Division of Emergency Medicine Department of Family & Community Medicine, University of Toronto School of Medicine. He later went on from 1999 – 2007 as the Clinical Assistant Professor, Department of Family Medicine, at the University of Arizona. Dr. Bialek has practiced family medicine and emergency medicine for the Fort Apache Indian Reservation in Arizona as a Lieutenant Commander in the Commissioned Corps Indian Health Services for US Public Health Services. Academic Appointments include Engineering for Developing Communities in Israel, Nepal, and China.From 2005 – 2011, Dr. Balek was the Associate Adjunct Professor, Engineering and Applied Sciences at the University of Colorado Boulder. Today, Dr. Bialek holds medical licensure in Colorado, Ontario, and South Dakota. He has practices in family medicine specializing in Medicinal Cannabis throughout Colorado, and is a member of the Medical Cannabis Research Group at CU Boulder. Dr. Bialek will be the medical director for the A.C.T Now Program, Native American Medical Liaison, and the assistant medical director for clinical human observational studies.


Lorin Cohen (Public Relations and Communications)
Lorin Cohen previously worked as a corporate relations manager for the American Stock Exchange, accounts executive for Lippert/Heilshorn & Associates, and currently runs her own public relations firm. Lorin Cohen received her MBA, Finance from New York University – Learnard N. Stern School of Business, and her B.S., Finance and Marketing – Lehigh University. Ms. Cohen provides public relations consulting services for the company.


Please take time to listen to this interview with UCANN CEO Earnest Blackmon:
UCANN has developed the world's first comprehensive full sprecturm advanced proprietary cannabiniod therapy program

Our patent-pending Prana Bio Nutrient Medicinals provide physicians and patients a limitless guide to sequencing cannabinoids specific to conditions. Prana Bio Nutrient Medicinals are formulated from a variety of whole plant CBD-Rich and THC strains with specific profiles that are divided into 4 categories P1, P2, P3, P4.

 A.C.T (Advanced Cannabinoid Therapy) Program
The A.C.T Now Program is a comprehensive full spectrum cannabinoid therapy guide that utilizes the entire cannabis plant by controlling specific cannabinoid ratios, accurate dosing, and multiple non-abrasive delivery methods.

A.C.T (Advanced Cannabinoid Therapy) Software
The A.C.T Now software is the first in the world to offer physicians a HIPPA-friendly cloud based EHR software for charting, scheduling, e-visits appointments, billing, reports, and an integrated patient portal.

UC Nevada LLC
UC Nevada LLC, a wholly owned subsidary of United Cannabis, is the managing partner in a group that has received provisional licenses for the cultivation, production and processing of cannabis in Clark County, Las Vegas, Nevada. UC Nevada LLC has already procured and received zoning approval on a 22- acre, secure facility which will serve as headquarters for the Nevada operation.

Harborside Health Center of California is considered the gold standard for cannabis innovation, activism, medicine, and compassion. Harborside has one of the most recognized medical cannabis brands in the world with nearly a decade of experience in the California market. United Cannabis provides Harborside Health Center with exclusive rights to the distribution of Prana Bio Nutrient Medicinals and the A.C.T. Now extended services throughout the State of California. Together, this relationship will provide patients of California access to an affordable, all natural, healthy, and safe alternative to pharmaceuticals.

Marcus Richardson aka Bubbleman is the owner of Fresh Headies, the creator of Bubble Bags, and producer of the renown YouTube Channel known as Bubblemans world.  He is a federally-exempt cannabis patient, hash maker with over 20 years of experience, and widely respected world wide throughout the cannabis industry. United Cannabis is the US brand ambassador for the Bubble Man brand

Prana Bio Nutrient Medicinals offer a wide selections of raw and active cannabinoid supplements with multiple delivery methods that have accurately dosed medicine from 1mg to 100mg. These products and patient-driven programs are designed to help regulate the body’s endogenous endocannabinoid system, perhaps the most physiological system in maintaining human health. Thes products are used in conjunction with the extended services provided by the A.C.T. Now Program.
DNA Genetics is a world leader in cannabis genetic research and development. Attributed with the cultivation of hundreds of cannabis strains, DNA Genetics has won more than 125 awards across the globe for their contributions to the industry, including nine for the development of the medicinal LA Confidential, the first pure Indica strain in the world to be genome sequenced and genetically mapped.
United Cannabis will serve as the exclusive distributor for DNA Genetics in Colorado, with first right of refusal in all US territories.

The FoxBarry group of companies provides a variety of economic development opportunities to its Native American partners. Working directly with its tribal partners, FoxBarry provides funding and management expertise in turnkey business enterprises that work within the constructs of the laws and ordinances of the tribes.
On December 11, 2014, the Department of Justice announced that Native American tribes can grow or sell marijuana on their lands as long as they comply with the federal conditions laid out for states that have legalized medical marijuana and medical marijuana infused products
FoxBarry is currently planning programs to serve North, Central and Southern California, and has pledged $30 million to establish the initial three sites. United Cannabis will work directly with FoxBarry to develop ordinances that comply with the various statutes in Colorado, California and Washington State as well as Federal guidelines.

FoxBarry Farms, LLC Will Be the Exclusive Producer and Distributor for All United Cannabis Branded Products in California 

United Cannabis Corporation has partnered with a group of Jamaicans to establish a marijuana medical research lab in Jamaica.The venture has a 30,000 square-foot facility in Kingston's "industrial zone" to serve as the corporate headquarters for the Jamaican firm, Cannabinoid Research and Development Company.The move is meant to position the US-based company, which has a 50 per cent stake in the Jamaican entity, to benefit from legislation that is expected to decriminalise marijuana for medical purposes by the end of the year.

United Cannabis provides Blue River Extracts global utility patents rights for the use of terpenes as a diluent in aromatherapy, vaporization, essential oils, edibles, aerosols, and for product branding purposes. Blue River provides full spectrum aromatherapy and essential oil profiles are derived naturally from specific plant based cultivars utilizing a proprietary chemical-free process.  Terpenes are produced by countless plant species, prevalent in fruits, vegetables, herbs, spices, and other botanicals. Terpenes are also common ingredients in the human diet and have generally been recognized as safe to consume by the US Food and Drug Administration.




Additional Recent News

[Marketwired] – United Cannabis Corp. today announced that it has entered into a farm lease with INTIVA Real Estate Colorado LLC on an 80-acre property in Pueblo, Colorado
[Accesswire] – United Cannabis Corp. Files for Patents on Unique Combinations of Pharmaceutically Active Cannabinoids
[Accesswire] – United Cannabis Corp. Partners and Affiliates Secure 14 Top Prizes in November Cannabis Competitions  

CNAB Security Details
Share Structure
  Market Value1 $55,007,028 a/o Nov 25, 2016
Authorized Shares 100,000,000 a/o Oct 26, 2016
Outstanding Shares 47,832,198 a/o Nov 11, 2016
-Restricted 37,897,588 a/o Oct 26, 2016
-Unrestricted 10,641,660 a/o Oct 26, 2016
Held at DTC 10,621,660 a/o Oct 26, 2016
  Float 11,180,860 a/o Jul 06, 2016
  Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Direct Transfer, LLC.
Shareholders of Record 56 a/o Oct 06, 2016
Corporate Actions
  Ex. Date Record Date Pay Date
Dividend (0.00) Mar 24, 2014 Mar 19, 2014 Mar 21, 2014


Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNAB News: Current Report Filing (8-k) 06/25/2018 05:04:19 PM
CNAB News: Notice of Effectiveness (effect) 05/22/2018 06:01:57 AM
CNAB News: Statement of Changes in Beneficial Ownership (4) 05/18/2018 06:51:45 PM
CNAB News: Securities Registration Statement (s-1/a) 05/17/2018 06:18:52 AM
CNAB News: Statement of Changes in Beneficial Ownership (4) 05/16/2018 11:31:16 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#5089   #CNAB: The time has come for ...:-} captainscotty 07/16/18 07:35:45 AM
#5088   Ready! The quiet times were gifts! a surfer 07/15/18 07:02:10 PM
#5087   #CNAB: We have been hanging out here for captainscotty 07/15/18 01:07:02 PM
#5086   Dude nice find!!! Prana new Panzer weapon of choice!!! Panzer 07/15/18 12:01:20 PM
#5085   This will be Panzers best 2018-2019 stock. $10+ Panzer 07/15/18 12:00:10 PM
#5084   Beam me up CNAB shares captainscotty!!! Panzer 07/15/18 11:59:14 AM
#5083 captainscotty 07/14/18 04:07:02 PM
#5082   #CNAB: PANZER'S UNITED FRONT...:-} $0.74 captainscotty 07/14/18 03:54:37 PM
#5081   #CNAB: Social Media World...:-} captainscotty 07/14/18 03:52:14 PM
#5080   #CNAB: Room to grow...:-} Herr PANZER captainscotty 07/14/18 03:47:58 PM
#5079   #CNAB: Time to ride the $CNAB Horse...:-} captainscotty 07/14/18 03:46:37 PM
#5078   Big volume day proceeds massive gains CNAB Panzer 07/14/18 02:12:52 PM
#5077   My $25 prediction will happen maybe more. Panzer 07/14/18 02:12:14 PM
#5076   I believe this to be a $25 stock Panzer 07/14/18 02:10:50 PM
#5075   I am personally putting over 100K at these Panzer 07/14/18 02:10:16 PM
#5074   I figure Between 15 and 20 percent of Jamie7613 07/14/18 01:53:28 PM
#5073   AEXG known to sell shares for the company. Panzer 07/13/18 03:54:02 PM
#5072   Agreed. Flippers taking some small profits here. No worries. Ex-Bagholder 07/13/18 01:25:45 PM
#5071   With 2 million in Revenue last quarter. Selling Jamie7613 07/13/18 01:01:28 PM
#5070   Appears the company still selling some shares to Panzer 07/13/18 12:35:52 PM
#5069   Excellent news - thanks for sharing that link! Jaymeinnyc 07/13/18 12:24:08 PM
#5068   When do you guys think the news will Ex-Bagholder 07/13/18 12:17:15 PM
#5067   Can you sticky recent news and all current Ex-Bagholder 07/13/18 11:30:38 AM
#5066   Just look at the share structure just probably Jamie7613 07/13/18 11:21:30 AM
#5065   If you compare our valuation to canopy growth Jamie7613 07/13/18 11:14:43 AM
#5064   Soon my friend. I bet we see paper Ex-Bagholder 07/13/18 11:14:43 AM
#5063   This is a $25+ no one home knows about. Panzer 07/13/18 10:21:48 AM
#5062   Let it fly Jamie7613 07/13/18 10:15:34 AM
#5061   Once this news is uploaded to the TD Ex-Bagholder 07/13/18 10:10:28 AM
#5060   The tone seemed to imply we’re running at Ex-Bagholder 07/13/18 09:55:38 AM
#5059   I want to know what percentage of capacity Jamie7613 07/13/18 01:22:49 AM
#5058   $10 mil revenue projection for 2018 Ex-Bagholder 07/12/18 03:55:01 PM
#5057 Ex-Bagholder 07/12/18 03:40:44 PM
#5056   BOOM CNAB Panzer 06/30/18 06:06:07 PM
#5055   We have taken a position based off Patent held. PatentPlays 06/29/18 09:18:20 PM
#5054   CNAB perfect buy range Panzer 06/28/18 11:35:02 AM
#5053   Panzer moving CNAB divisions into attack formation Panzer 06/28/18 11:34:40 AM
#5052   It could de schedule it today with the Jamie7613 06/25/18 03:04:07 PM
#5051   Within 90 days. Hopefully sooner Jamie7613 06/25/18 03:01:23 PM
#5050   Schedule 1 must be removed soon too I a surfer 06/25/18 02:30:38 PM
#5049   First FDA cannabis drug just approved Jamie7613 06/25/18 02:26:18 PM
#5048   Senator McConnell is working on attaching a hemp Jamie7613 06/24/18 09:51:29 PM
#5047   Darn it I was going to buy more!!! Panzer 06/21/18 04:30:56 PM
#5046   Bulls finally stepping in... a surfer 06/21/18 03:05:34 PM
#5045   Just wait and load up in the dead pokerpunk 06/15/18 02:28:26 PM
#5044   This stock sucks major ass!!! Mavi Dreams 06/15/18 11:18:55 AM
#5042   "We're on the cusp of a major-shift in-sentiment rjunior79 04/23/18 03:10:54 AM
#5041   Panel recommends FDA approval of epilepsy drug derived Jamie7613 04/19/18 02:33:25 PM
#5040   Panel recommends FDA approval of epilepsy drug derived Jamie7613 04/19/18 02:22:10 PM
#5039   Jesús Vázquez, Intellectual Property Attorney, Joins United Cannabis Jamie7613 04/18/18 08:05:18 PM